Bortezomib in multiple myeloma.
Vandenbroucke
Jan P
JP
Kroep
Judith R
JR
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001897:Boronic Acids / Q000627:therapeutic use*; D000069286:Bortezomib; D003627:Data Interpretation, Statistical; D003907:Dexamethasone / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006801:Humans; D009101:Multiple Myeloma / Q000188:drug therapy* / Q000401:mortality; D011719:Pyrazines / Q000627:therapeutic use*; D012008:Recurrence; D012107:Research Design; D016019:Survival Analysis
D000970:Antineoplastic Agents; D001897:Boronic Acids; D011719:Pyrazines; D000069286:Bortezomib; D003907:Dexamethasone